Replies to post #221784 on Biotech Values

[DewDiligence]

(REGN)—Roche’s_Faricimab_dosed_q8w_shows_NI_to_Eylea_in DME:

https://www.roche.com/investors/updates/inv-update-2020-12-21.htm

Faricimab is a bi-specific mAb that targets VEGF-A and Ang-2.